-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster II

Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Angela Huynh, PhD1,2, Donald M. Arnold, MD1,3, James W. Smith1*, Rumi Clare, BSc1*, Nikola Ivetic, BSc1, Jane C. Moore, BSc, MT1*, John G. Kelton, MD1,3 and Ishac Nazy, PhD1

1Michael G. DeGroote School of Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada
2Schulich School of Medicine & Dentistry, Western University, London, ON, Canada
3McMaster Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada

Quan Zhang*, Zhan Ye, M.D, Ph.D.*, Antonia Bignotti, B.A.* and X. Long Zheng, MD, PhD

Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS

Tammuella Chrisentery-Singleton, MD1, Lisa N Boggio, MD, MS2, Manuel Carcao, MD, MSc3, Sami Ibrahimi, MD, FRCPC, MSc4*, Osman Khan, MD, MS5*, Arash Mahajerin6, Anita Rajasekhar, MD7, Vivek Sharma8*, MacGregor Steele9*, Marcela Torres, MD10 and Shannon L Carpenter, MD, MS11

1Mississippi Center for Advanced Medicine, Madison, MS
2Rush Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, IL
3The Hospital for Sick Children, Toronto, ON, Canada
4OUHSC/Stephenson Cancer Center, Oklahoma City
5University of Oklahoma Health Sciences Center, Oklahoma City
6Children's Hospital of Orange County, Orange, CA
7University of Florida - Shands Hospital, Gainesville, FL
8University of Louisville, Louisville
9Alberta Children's Hospital, Edmonton, AB, Canada
10Department of Hematology, Cook Children's Medical Center, Fort Worth, TX
11Children's Mercy Hospital, Kansas City, MO

Damon E. Houghton, MD, MS1,2, Ewa Wysokinska, MD3, Ana I. Casanegra, MD4*, Leslie Padrnos, MD5, Surbhi Shah, MBBS6*, Waldemar E. Wysokinski, MD, PhD4*, Rajiv K. Pruthi, M.B.B.S7, Heather A Heaton, MD, MS8* and Robert D. McBane, MD4*

1Dept of Cardiovascular Diseases, Division of Vascular Medicine & Dept of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
2Gonda Vascular Center, Mayo Clinic, Rochester, MN
3Mayo Clinic, Jacksonville, FL
4Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
5Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
6Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
7Division of Hematology, Mayo Clinic, Rochester, MN
8Emergency Medicine, Mayo Clinic, Rochester, MN

Patrick Van Dreden, PhD1,2, Salahdin Khelifi Otmane3*, Grigorios T. Gerotziafas4,5*, Matthieu Grusse6*, Aurélie Rousseau, Ph.D7,8*, Lila Louadj3* and Michele Sabbah9*

1Cancer biology and Therapeutics INSERM U938, Faculté de Medecine Pierre et Marie Curie, Université Paris VI, Paris, France
2Clinical Research department, Stago, Gennevilliers, France
3INSERM U938, Cancer biology and therapeutics, Hôpital Saint-Antoine, Paris, France
4Service d'Hématologie Biologique Hôpital Tenon, Paris, France, Paris, France
5INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI,, Paris, France
6Clinical Research department, Diagnostica Stago, Gennevilliers, France
7Clinical Research Department, Diagnostica Stago, Gennevilliers, France
8INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, Paris,France, Paris, France
9Centre de Recherches Saint-Antoine-CRSA / Cancer biology and therapeutics, Hôpital Saint-Antoine, Paris, France

Johanna A. Kremer Hovinga Strebel, MD1, Javier de la Rubia, MD2*, Katerina Pavenski, MD, FRCPC3, Ara Metjian, MD4, Paul Knoebl, MD5*, Flora Peyvandi, MD6,7, Spero Cataland, MD8, PAUL Coppo9*, Umer Khan, MS10*, Laurel A. Menapace, MD11, Ana Paula Marques, MD12*, Sriya Gunawardena, MD13* and Marie Scully, MD14

1Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland
2Hematology Department, University Hospital La Fe, Valencia, Spain
3Departments of Medicine and Laboratory Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Canada
4University of Colorado Anschutz Medical Campus, Aurora, CO
5Division of Hematology and Hemostasis, Department of Medicine 1, Medical University of Vienna, Vienna, Austria
6Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
7Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
8Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
9Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France
10Sanofi, San Diego, CA
11Rare Blood Disorder Therapeutic Area, Sanofi, Cambridge, MA
12Sanofi, Sao Paulo, Brazil
13Sanofi, Cambridge, MA
14Cardiometabolic Programme, NIHR UCLH/UCL BRC, Department of Haematology, University College London Hospital, London, United Kingdom

Huyen Tran, MBBS1,2*, Lucy Deng, MBBS, PhD, FRACP3*, Nicholas Wood, MBBS, PhD, FRACP4* and Vivien M Chen, MBBS, PhD5

1Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
2Haemostasis & Thrombosis Unit, Haemophilia Treatment Centre, The Alfred Hospital, Melbourne, VIC, Australia
3National Centre for Immunisation Research and Surveillance, Sydney, Australia
4National Centre for Immunisation Research and Surveillance Australia, Sydney, Australia
5ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia

Anthony C Stack, DO1, Samuel J Black, MD, PhD2*, Brinda Gupta, MD3, Huaqing Zhao, MS, PhD4* and Nadia D Ali, MD5

1Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA
2Department of Medicine, Temple University Hospital, Philadelphia, PA
3Division of Hematology/Oncology, Georgetown University Medical Center, Washington, DC
4Lewis Katz School of Medicine at Temple University, Philadelphia, PA
5Section of Hematology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA

Arya Mariam Roy, MBBS1, Aravind Mohanakumar Warrier, MS2*, Hassan Awada, MD1*, Sheeba Ba Aqeel, MD3, Karan Jatwani, MD1*, Alankrita Taneja, MBBS3 and Amanda Przespolewski, DO3*

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Thought Spot, Mountain View, CA
3Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Can Jones, MD1, Kristina Menchaca, MD2*, Catherine Ostos, MD2*, Jeffery Durbin, MS3*, Kai Chen, MD4* and Shachar Peles, MD5*

1University of Miami / Palm Beach Regional GME Consortium, West palm beach, FL
2University of Miami / Palm Beach Regional GME Consortium, Atlantis, FL
3HCA Healthcare Physician Services Group, Brentwood, TN
4Cardiology, University of Florida College of Medicine, Jacksonville
5Florida Cancer Specialists, Atlantis, FL

*signifies non-member of ASH